Mapping domains and mutations on the skeletal muscle ryanodine receptor channel

Trends in Molecular Medicine

Volumn 18, Issue 11, 2012, Pages 644-657

  Hwang, Jean H ^a   Zorzato, Francesco ^b,c   Clarke, Nigel F ^a,d   Treves, Susan ^b,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Calcium signaling; Disease pathogenesis; Domains; Excitation contraction coupling; Protein interactions; Ryanodine receptor type 1; Skeletal muscle

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; ADENOSINE TRIPHOSPHATE; CALCIUM ION; CALMODULIN; CALSEQUESTRIN; COMPLEMENTARY DNA; CYTOPLASM PROTEIN; DANTROLENE; FK 506 BINDING PROTEIN; MAGNESIUM ION; PROTEIN HOMER; PROTEIN S 100; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RYANODINE RECEPTOR 1; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SELENOPROTEIN; SMALL MOLECULE TRANSPORT AGENT; TACROLIMUS;

ALTERNATIVE RNA SPLICING; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CENTRAL CORE DISEASE; CENTRONUCLEAR MYOPATHY; CRYOELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; GENE EXPRESSION; GENE MAPPING; GENE MUTATION; HUMAN; MALIGNANT HYPERTHERMIA; MUSCLE CONTRACTION; MUSCLE DISEASE; NONHUMAN; OXIDATION REDUCTION STATE; PATHOGENESIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE;

ANIMALS; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; HUMANS; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUTATION; PROTEIN BINDING; PROTEIN INTERACTION MAPS; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 84868194081     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2012.09.006     Document Type: Review

References (125)

1. Takeshima H., et al. Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature 1994, 369:556-559.
2. Treves S., et al. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. Curr. Opin. Pharmacol. 2008, 8:319-326.
3. Clarke N.F., et al. Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion. Hum. Mutat. 2010, 31:E1544-E1550.
4. Wilmshurst J., et al. RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann. Neurol. 2010, 68:717-726.
5. Fill M., Copello J.A. Ryanodine receptor calcium release channels. Physiol. Rev. 2002, 82:893-922.
6. Zhao M., et al. Molecular identification of the ryanodine receptor pore-forming segment. J. Biol. Chem. 1999, 274:25971-25974.
7. Gillespie D., et al. (De) constructing the ryanodine receptor: modeling ion permeation and selectivity of the calcium release channel. J. Phys. Chem. B 2005, 109:15598-15610.
8. Ramachandran S., et al. A structural model of the pore-forming region of the skeletal muscle ryanodine receptor (RyR1). PLoS Comput. Biol. 2009, 5:e1000367.
9. Van Petegem F. Ryanodine receptors: structure and function. J. Biol. Chem. 2012, 287:31624-31632.
10. 2+ and AMP-PCP. Biophys. J. 1999, 77:1936-1944.
11. 2+ channel regulation. Trends Cardiovasc. Med. 2000, 10:310-316.
12. Sharma M.R., et al. Three-dimensional structure of ryanodine receptor isoform three in two conformational states as visualized by cryo-electron microscopy. J. Biol. Chem. 2000, 275:9485-9491.
13. Ikemoto N., Yamamoto T. Regulation of calcium release by interdomain interaction within ryanodine receptors. Front. Biosci. 2002, 7:d671-d683.
14. 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 1996, 271:22759-22763.
15. Bannister M.L., et al. Malignant hyperthermia mutation sites in the Leu2442-Pro2477 (DP4) region of RyR1 (ryanodine receptor 1) are clustered in a structurally and functionally definable area. Biochem. J. 2007, 401:333-339.
16. Futatsugi A., et al. Tissue-specific and developmentally regulated alternative splicing in mouse skeletal muscle ryanodine receptor mRNA. Biochem. J. 1995, 305:373-378.
17. Zorzato F., et al. Identification of two ryanodine receptor transcripts in neonatal, slow-, and fast-twitch rabbit skeletal muscles. Biochem. Biophys. Res. Commun. 1994, 203:1725-1730.
18. 2+-ATPase in myotonic dystrophy type 1. Hum. Mol. Genet. 2005, 14:2189-2200.
19. Kimura T., et al. A variably spliced region in the type 1 ryanodine receptor may participate in an inter-domain interaction. Biochem. J. 2007, 401:317-324.
20. Nakai J., et al. Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature 1996, 380:72-75.
21. Sheridan D.C., et al. Bidirectional signaling between calcium channels of skeletal muscle requires multiple direct and indirect interactions. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:19760-19765.
22. Rebbeck R.T., et al. The β1a subunit of the skeletal DHPR binds to skeletal RyR1 and activates the channel via its 35-residue C-terminal tail. Biophys. J. 2011, 100:922-930.
23. Leong P., MacLennan D.H. A 37-amino acid sequence in the skeletal muscle ryanodine receptor interacts with the cytoplasmic loop between domains II and III in the skeletal muscle dihydropyridine receptor. J. Biol. Chem. 1998, 273:7791-7794.
24. Protasi F., et al. Multiple regions of RyR1 mediate functional and structural interactions with α1S-dihydropyridine receptors in skeletal muscle. Biophys. J. 2002, 83:3230-3244.
25. Proenza C., et al. Identification of a region of RyR1 that participates in allosteric coupling with the 1S (CaV1. 1) II-III loop. J. Biol. Chem. 2002, 277:6530-6535.
26. Altafaj X., et al. Maurocalcine and domain A of the II-III loop of the dihydropyridine receptor Cav 1.1 subunit share common binding sites on the skeletal ryanodine receptor. J. Biol. Chem. 2005, 280:4013-4016.
27. Casarotto M.G., et al. Structural and functional characterization of interactions between the dihydropyridine receptor II-III loop and the ryanodine receptor. Clin. Exp. Pharmacol. Physiol. 2006, 33:1114-1117.
28. Peralvarez-Marin A., et al. 3D mapping of the SPRY2 domain of ryanodine receptor 1 by single-particle cryo-EM. PLoS ONE 2011, 6:e25813.
29. Cui Y., et al. A dihydropyridine receptor α1s loop region critical for skeletal muscle contraction is intrinsically unstructured and binds to a SPRY domain of the type 1 ryanodine receptor. Int. J. Biochem. Cell Biol. 2009, 41:677-686.
30. 2+ channel-subunit and ryanodine receptor type 1 strengthens excitation-contraction coupling. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:19225-19230.
31. Beam K.G., Bannister R.A. Looking for answers to EC coupling's persistent questions. J. Gen. Physiol. 2010, 136:7-12.
32. Yamazawa T., et al. A region of the ryanodine receptor critical for excitation-contraction coupling in skeletal muscle. J. Biol. Chem. 1997, 272:8161-8164.
33. Perez C.F., et al. Amino acids 1-1,680 of ryanodine receptor type 1 hold critical determinants of skeletal type for excitation-contraction coupling. J. Biol. Chem. 2003, 278:39644-39652.
34. 2+ signal amplification in excitation-contraction coupling. EMBO J. 1996, 15:6172-6177.
35. 2+ channels. J. Biol. Chem. 1998, 273:13403-13406.
36. Prosser B.L., et al. S100A1 and calmodulin regulation of ryanodine receptor in striated muscle. Cell Calcium 2011, 50:323-331.
37. 2+-calmodulin bind to neighboring locations on the ryanodine receptor. J. Biol. Chem. 2002, 277:1349-1353.
38. 2+ sparks in frog skeletal muscle. J. Biol. Chem. 2005, 280:11713-11722.
39. Menegazzi P., et al. Identification and characterization of three calmodulin binding sites of the skeletal muscle ryanodine receptor. Biochemistry 1994, 33:9078-9084.
40. 2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 1994, 269:22698-22704.
41. 2+ release channel, ryanodine receptor. J. Biol. Chem. 2001, 276:22579-22585.
42. Rodney G.G., et al. Calcium binding to calmodulin leads to an N-terminal shift in its binding site on the ryanodine receptor. J. Biol. Chem. 2001, 276:2069-2074.
43. 2+ release channel. J. Biol. Chem. 2003, 278:8348-8355.
44. Wright N.T., et al. S100A1 and calmodulin compete for the same binding site on ryanodine receptor. J. Biol. Chem. 2008, 283:26676-26683.
45. 2+ release channel (ryanodine receptor) of skeletal muscle. Biochemistry 1997, 36:11496-11503.
46. Prosser B.L., et al. S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling. J. Biol. Chem. 2008, 283:5046-5057.
47. Prosser B.L., et al. S100A1 promotes action potential-initiated calcium release flux and force production in skeletal muscle. Am. J. Physiol. Cell Physiol. 2010, 299:C891-C902.
48. 2+ release in skeletal muscle expressing ryanodine receptor impaired in regulation by calmodulin and S100A1. Am. J. Physiol. Cell Physiol. 2011, 300:C998-C1012.
49. Qi Y., et al. FK-binding protein is associated with the ryanodine receptor of skeletal muscle in vertebrate animals. J. Biol. Chem. 1998, 273:34813-34819.
50. Ahern G.P., et al. Subconductance states in single-channel activity of skeletal muscle ryanodine receptors after removal of FKBP12. Biophys. J. 1997, 72:146-162.
51. Shou W., et al. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature 1998, 391:489-492.
52. Avila G., et al. FKBP12 binding to RyR1 modulates excitation-contraction coupling in mouse skeletal myotubes. J. Biol. Chem. 2003, 278:22600-22608.
53. Gaburjakova M., et al. FKBP12 binding modulates ryanodine receptor channel gating. J. Biol. Chem. 2001, 276:16931-16935.
54. Tang W., et al. Altered excitation-contraction coupling with skeletal muscle specific FKBP12 deficiency. FASEB J. 2004, 18:1597-1599.
55. 2+ release channels (ryanodine receptors). Science 1998, 281:818-821.
56. Wagenknecht T., et al. Locations of calmodulin and FK506-binding protein on the three-dimensional architecture of the skeletal muscle ryanodine receptor. J. Biol. Chem. 1997, 272:32463-32471.
57. Cornea R.L., et al. Mapping the ryanodine receptor FK506-binding protein subunit using fluorescence resonance energy transfer. J. Biol. Chem. 2010, 285:19219-19226.
58. Serysheva I.I., et al. Subnanometer-resolution electron cryomicroscopy-based domain models for the cytoplasmic region of skeletal muscle RyR channel. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9610-9615.
59. Kobayashi Y.M., et al. Localization and characterization of the calsequestrin-binding domain of triadin 1. J. Biol. Chem. 2000, 275:17639-17646.
60. Lee J.M., et al. Negatively charged amino acids within the intraluminal loop of ryanodine receptor are involved in the interaction with triadin. J. Biol. Chem. 2004, 279:6994-7000.
61. Wang Y., et al. Altered stored calcium release in skeletal myotubes deficient of triadin and junctin. Cell Calcium 2009, 45:29-37.
62. Oddoux S., et al. Triadin deletion induces impaired skeletal muscle function. J. Biol. Chem. 2009, 284:34918-34929.
63. Goonasekera S.A., et al. Triadin binding to the C-terminal luminal loop of the ryanodine receptor is important for skeletal muscle excitation-contraction coupling. J. Gen. Physiol. 2007, 130:365-378.
64. Wei L., et al. Junctin and triadin each activate skeletal ryanodine receptors but junctin alone mediates functional interactions with calsequestrin. Int. J. Biochem. Cell Biol. 2009, 41:2214-2224.
65. MacLennan D.H., Wong P. Isolation of a calcium-sequestering protein from sarcoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 1971, 68:1231-1235.
66. Perez C.F. On the footsteps of triadin and its role in skeletal muscle. World J. Biol. Chem. 2011, 2:177-183.
67. Beard N.A., et al. Calsequestrin is an inhibitor of skeletal muscle ryanodine receptor calcium release channels. Biophys. J. 2002, 82:310-320.
68. Ryan T., et al. Identification of novel ryanodine receptor 1 (RyR1) protein interaction with calcium homeostasis endoplasmic reticulum protein (CHERP). J. Biol. Chem. 2011, 286:17060-17068.
69. 2+ mobilization and decreases cell proliferation. Biochem. J. 2000, 348:189-199.
70. Duncan R.S., et al. Effects of Vesl/Homer proteins on intracellular signaling. Exp. Biol. Med. 2005, 230:527-535.
71. Pouliquin P., Dulhunty A.F. Homer and the ryanodine receptor. Eur. Biophys. J. 2009, 39:91-102.
72. Xia R., et al. Selenium compounds modulate the calcium release channel/ryanodine receptor of rabbit skeletal muscle by oxidizing functional thiols. Biochem. Pharmacol. 2004, 67:2071-2079.
73. Jurynec M.J., et al. Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:12485-12490.
74. Zorzato F., et al. Functional effects of mutations identified in patients with multiminicore disease. IUBMB Life 2007, 59:14-20.
75. 2+. J. Gen. Physiol. 1986, 88:573-588.
76. 2+. J. Membr. Biol. 1997, 159:179-185.
77. 2+ inhibition of skeletal RyRs reconstituted as isolated channels or coupled clusters. J. Gen. Physiol. 2004, 124:741-758.
78. 2+ sites. Biophys. J. 2007, 92:3541-3555.
79. Diaz-Sylvester P.L., et al. Modulation of cardiac ryanodine receptor channels by alkaline earth cations. PLoS ONE 2011, 6:e26693.
80. Meissner G. Regulation of mammalian ryanodine receptors. Front. Biosci. 2002, 7:d2072-d2080.
81. 2+ release. Biochem. J. 1993, 291:757-763.
82. 2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 1992, 267:23318-23326.
83. 2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 1993, 268:13414-13421.
84. 2+ sensor. J. Biol. Chem. 1998, 273:14675-14678.
85. Bhat M.B., et al. Functional calcium release channel formed by the carboxyl-terminal portion of ryanodine receptor. Biophys. J. 1997, 73:1329-1336.
86. 2+ release channels (ryanodine receptors). J. Biol. Chem. 1999, 274:26120-26126.
87. Fessenden J.D., et al. Mutational analysis of putative calcium binding motifs within the skeletal ryanodine receptor isoform, RyR1. J. Biol. Chem. 2004, 279:53028-53035.
88. 2+-binding domain in RyR1 that interacts with the calmodulin binding site and modulates channel activity. Biophys. J. 2006, 90:173-182.
89. Laver D., et al. Magnesium inhibition of ryanodine-receptor calcium channels: evidence for two independent mechanisms. J. Membr. Biol. 1997, 156:213-229.
90. 2+ release. Cell Calcium 2012, 51:427-433.
91. 2+, and adenine nucleotides. Biochemistry 1986, 25:236-244.
92. 2+ on ATP binding. Biochemistry 2006, 45:9408-9415.
93. 2+ release channels in malignant hyperthermia. Biophys. J. 1997, 73:1913-1924.
94. Ogunbayo O.A., et al. Cyclic adenosine diphosphate ribose activates ryanodine receptors, whereas NAADP activates two-pore domain channels. J. Biol. Chem. 2011, 286:9136-9140.
95. Zima A.V., et al. Differential modulation of cardiac and skeletal muscle ryanodine receptors by NADH. FEBS Lett. 2003, 547:32-36.
96. Xia R., et al. Skeletal muscle sarcoplasmic reticulum contains a NADH-dependent oxidase that generates superoxide. Am. J. Physiol. Cell Physiol. 2003, 285:C215-C221.
97. 2+ release channel has an oxidoreductase-like domain. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:12155-12160.
98. Bellinger A.M., et al. Stressed out: the skeletal muscle ryanodine receptor as a target of stress. J. Clin. Invest. 2008, 118:445-453.
99. Witcher D., et al. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J. Biol. Chem. 1991, 266:11144-11152.
100. Dulhunty A.F., et al. Characteristics of irreversible ATP activation suggest that native skeletal ryanodine receptors can be phosphorylated via an endogenous CaMKII. Biophys. J. 2001, 81:3240-3252.
101. Rodriguez P., et al. Stoichiometric phosphorylation of cardiac ryanodine receptor on serine 2809 by calmodulin-dependent kinase II and protein kinase A. J. Biol. Chem. 2003, 278:38593-38600.
102. 2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ. Res. 2004, 94:e61-e70.
103. Reiken S., et al. PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle. J. Cell Biol. 2003, 160:919-928.
104. Hain J., et al. Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from skeletal muscle. Biophys. J. 1994, 67:1823-1833.
105. 2+. Cell Calcium 1997, 21:283-290.
106. Marks A.R., et al. Regulation of ryanodine receptors via macromolecular complexes: a novel role for leucine/isoleucine zippers. Trends Cardiovasc. Med. 2002, 12:166-170.
107. 2+ channels: modulation by the catalytic subunit of cAMP-dependent protein kinase?. Biochemistry 1995, 34:5120-5129.
108. Stange M., et al. Characterization of recombinant skeletal muscle (Ser-2843) and cardiac muscle (Ser-2809) ryanodine receptor phosphorylation mutants. J. Biol. Chem. 2003, 278:51693-51702.
109. Bellinger A.M., et al. Hypernitrosylated ryanodine receptor/calcium release channels are leaky in dystrophic muscle. Nat. Med. 2009, 15:325-330.
110. Sun J., et al. Classes of thiols that influence the activity of the skeletal muscle calcium release channel. J. Biol. Chem. 2001, 276:15625-15630.
111. Zissimopoulos S., et al. Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein. J. Biol. Chem. 2007, 282:6976-6983.
112. Zissimopoulos S., Lai F. Redox regulation of the ryanodine receptor/calcium release channel. Biochem. Soc. Trans. 2006, 34:919-921.
113. Aracena-Parks P., et al. Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1. J. Biol. Chem. 2006, 281:40354-40368.
114. Voss A.A., et al. Identification of hyperreactive cysteines within ryanodine receptor type 1 by mass spectrometry. J. Biol. Chem. 2004, 279:34514-34520.
115. Moore C.P., et al. A role for cysteine 3635 of RYR1 in redox modulation and calmodulin binding. J. Biol. Chem. 1999, 274:36831-36834.
116. Samsó M., et al. Internal structure and visualization of transmembrane domains of the RyR1 calcium release channel by cryo EM. Nat. Struct. Mol. Biol. 2005, 12:539-544.
117. Yano M., et al. Mechanisms of disease: ryanodine receptor defects in heart failure and fatal arrhythmia. Nat. Clin. Pract. Cardiovasc. Med. 2006, 3:43-52.
118. 2+ channel regulation. J. Biol. Chem. 2000, 275:11618-11625.
119. Hayek S.M., et al. Characterization of a calcium-regulation domain of the skeletal-muscle ryanodine receptor. Biochem. J. 2000, 351:57-65.
120. 2+ release channels: insight into molecular changes in genetically-linked myopathies. J. Muscle Res. Cell Motil. 2006, 27:351-365.
121. Hamada T., et al. Peptide probe study of the role of interaction between the cytoplasmic and transmembrane domains of the ryanodine receptor in the channel regulation mechanism. Biochemistry 2007, 46:4272-4279.
122. Monnier N., et al. Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores. Hum. Mutat. 2008, 29:670-678.
123. Duarte S.T., et al. Dominant and recessive RYR1 mutations in adults with core lesions and mild muscle symptoms. Muscle Nerve 2011, 44:102-108.
124. Zhou H., et al. Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul. Disord. 2010, 20:166-173.
125. Bevilacqua J.A., et al. Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganization. Neuropathol. Appl. Neurobiol. 2011, 37:271-284.